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Phage production in response to antibiotics varied among four isolates of a Pseudomonas aeruginosa
cystic fibrosis (CF) epidemic strain. Whereas ciprofloxacin induced higher levels of phage production,
other CF-relevant antibiotics led to reduced production. We detected free phages directly in CF patient
sputum samples by both plaque (40% positive) and PCR (76% positive) assays. Our observations suggest
that the choice of antibiotics could influence the number of free phages within the CF lung environment.
The Liverpool epidemic strain (LES) is the most common
cystic fibrosis (CF) epidemic strain of Pseudomonas aerugi-
nosa in the United Kingdom (12). The genome of the ear-
liest LES isolate (LESB58) has been sequenced, revealing
the presence of six prophages, five of which can produce
active phage progeny (14). Specific mutations within LES
prophages 2, 3, and 5 resulted in reduced competitiveness in
a rat chronic lung infection model (14). The aim of this
study was to determine the effects of different CF-relevant
antibiotics on the level of phage production by LES isolates.
The P. aeruginosa LES isolates (LES400, LES431, LESB58,
and LESB65) represent different phenotypic and pathogenic
variants (6). MICs of antimicrobial agents were determined
according to British Society for Antimicrobial Chemotherapy
guidelines (1). Sputum samples were collected from adult CF
patients chronically infected with the LES. Sputum was treated
with an equal volume of Sputasol (Oxoid, Basingstoke, United
Kingdom). PCR assays were performed as described previ-
ously (3, 5) for LES phages 2 and 3, respectively, on superna-
tants from culture and directly from CF patient sputum. All
PCR assays were performed in duplicate. Cultures were grown
to an optical density (A600) of 0.5, and phage induction was
performed by adding antibiotics at the MIC (norfloxacin, 50
g/ml; tobramycin, 4 g/ml; colistin, 1 g/ml; ceftazidime, 64
g/ml; meropenem, 2 g/ml; ciprofloxacin, 4 g/ml) and incu-
bation for 1 h, followed by 1 h of recovery in fresh medium.
Induced active phage particles were enumerated using plaque
assays in which 100 l of culture supernatant was added to 100
l (A600 of 0.5) of P. aeruginosa PAO1 (the indicator strain) in
5 ml of molten 0.4% Luria agar and poured onto L agar in
triplicate. PCR assays (3, 5) showed that the plaques obtained
were caused by a combination of LES phages 2 and 3. Statis-
tical analysis was performed using either a Kruskal-Wallis test
or a Mann-Whitney U test for significant differences.
The background level of spontaneous phage production
was low (50 to 1,000 PFU/ml), but there were significant
differences among the four LES isolates tested (Fig. 1).
Ciprofloxacin and norfloxacin caused a level of phage induc-
tion higher than that in uninduced cultures of each of the
isolates. Cultures treated with the other four CF-relevant
antibiotics resulted in reduced numbers of phages from all
of the LES isolates tested (Fig. 1). For LESB58 and LES400,
the presence of each different antibiotic significantly af-
fected the number of phages produced (Table 1).
Ciprofloxacin and norfloxacin, which induced the highest
phage numbers, affect DNA replication and repair, triggering
the SOS response and induction of the phage lytic cycle. Up-
regulation of phage-like genes in the presence of ciprofloxacin
has been shown previously for strain PAO1 (3). In the presence
of other CF-relevant antibiotics, the level of phage production
was less than the spontaneous induction level, suggesting that
some antibiotics may have an inhibitory effect on phage pro-
duction. Colistin can inhibit phage production in Mycobacte-
rium tuberculosis (4), possibly due to interruption of the cell
membrane, thereby disrupting binding sites required for phage
assembly (7). Colistin and meropenem target the cell mem-
brane and cell wall, respectively, and could have a similar effect
on the production of LES phages. A recent study showed that
the production of late gene phage products was affected dif-
ferently by different classes of subinhibitory antibiotic concen-
trations (10). Antibiotics affecting DNA synthesis caused up-
regulation of the late gene responsible for Shiga toxin
production (stx), whereas antibiotics affecting cell wall and
protein synthesis had an inhibitory effect (10). This phenome-
non was particularly pronounced in the presence of azithro-
mycin. We found that the presence of azithromycin caused a
significant decrease in phage production by three isolates
(LESB58, LESB65, and LES400). Considerable variation in
phage production was observed among the different LES iso-
lates, adding further to the different characteristics exhibited
by LES isolates (8).
PCR and plaque assays were performed on 58 sputum
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samples from CF patients chronically infected with the LES.
Plaques caused by LES phage 2 or 3 were identified in 40%
of the samples by plaque assays. Using PCR assays, LES
phage 2 or 3 was identified in 74% of the Sputasol-treated,
filter-sterilized, DNase I-treated sputum samples. Both
phages were present together in 59% of the samples tested.
The high rate of detection of these phages in CF sputum
may be due to induction by the high levels of oxidative stress
and the abundance of inflammatory cells in the CF lung
(11). In addition, intensive antibiotic treatment regimens
are often used particularly during periods of exacerbation.
Phages have been linked with horizontal gene transfer
between closely related species and have been associated
with virulence in many other bacterial hosts (5). Pseudomo-
nas phages have also been associated with the formation of
biofilms (13). The importance of lysogenic Pseudomonas
phages remains poorly understood, but LES prophages 2
and 3 have been implicated in the establishment of chronic
infection in an animal model (10). It is possible that the
prophages contain genes that are only activated during the
process of induction leading to phage production. As has
been suggested for Staphylococcus (9), phage mobilization
in P. aeruginosa populations may contribute to adaptation in
the CF airway through the production of increased diversi-
fication (4).
This is the first demonstration of active LES phages (de-
tected by plaque assay) present in CF sputum. Our data
suggest that the choice of antibiotic used in CF lung infec-
tion management could dramatically affect the levels of free
Pseudomonas phages in the CF lung. P. aeruginosa phage
mobilization has been associated with increased diversifica-
tion (4) and the transduction of antibiotic resistance (2).
Given the roles of phages in promoting horizontal gene
transfer (2), modulating biofilm formation (9), and increas-
ing the competitiveness (10) of this important CF pathogen,
our findings suggest that the choice of antibiotic therapy
FIG. 1. Levels of phage production by four LES isolates in PFU per milliliter. Cultures (n  9 for each isolate) were either uninduced
(spontaneous phage induction) or treated with the appropriate antibiotic at the MIC. Asterisks signify isolates with phage production significantly
different (P  0.05) from that of LESB58 under each condition. Statistical analysis was performed using the Kruskal-Wallis test and Dunn’s test
for nonparametric data.
TABLE 1. Phage production in the presence of antibiotics
Isolate
P valuea
Norfloxacin Ciprofloxacin Tobramycin Meropenem Azithromycin Colistin
LESB58 0.001b 0.004b 0.001b 0.006b 0.001b 0.006b
LESB65 0.001b 0.05 0.001b 0.001b 0.001b 0.001b
LES400 0.001b 0.001b 0.001b 0.001b 0.001b 0.001b
LES431 0.001b 0.001b 0.063 0.222 0.796 0.031b
a Analysis was performed using a Mann-Whitney U test for statistically significant differences. For each LES isolate, the difference in phage production between
uninduced cultures and antibiotic-treated cultures was tested (n  9 for each isolate under each condition).
b Statistically significant difference associated with the presence of antibiotic.
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may be important in the adaptation of P. aeruginosa popu-
lations to the CF lung through increased or decreased levels
of free phage.
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